Related Experiment Video
Updated: Sep 16, 2025
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
The Significance of STAT3 in Colonic Diseases: A Comprehensive Study of Pathological Roles and Therapeutic
Abdulrahman T Ahmed1, Enwa Felix Oghenemaro2, Ahmed Hjazi3
1College of Nursing, University of Al Maarif, Al Anbar, 31001, Iraq. Abdulrahman.dheyab@uoa.edu.iq.
Abstract:
The transcriptional regulator signal transducer and activator of transcription 3 (STAT3) plays pivotal roles in vertebrate development and the functionality of mature tissues, particularly in modulating inflammation and immune responses. Mutations in STAT3 in humans are associated with various diseases, including immunodeficiencies, autoimmune disorders, and multiple cancers. Notably, both aberrant hyperactivation and inactivation of STAT3 are linked to disease manifestations, underscoring the need for tightly regulated STAT3 activity to maintain health. In inflammatory bowel disease (IBD), STAT3 exhibits abnormal activation in colonic tissues, primarily driven by a range of pro-inflammatory cytokines. This dysregulation compromises the integrity of the intestinal mucosal barrier and leads to an exaggerated innate immune response and heightened Th17 cell activity. Moreover, persistent STAT3 activation is implicated in the pathogenesis of colorectal cancer (CRC), highlighting its critical regulatory role in inflammation associated with cancer-induced colitis. Elevated STAT3 expression is frequently observed in CRC cases. This study delves into STAT3's multifaceted roles in various cellular processes, including proliferation, migration, differentiation, motility, and the inflammatory response, specifically focusing on their implications in colitis and colorectal cancer. We further explore therapeutic strategies to modulate STAT3 signaling pathways, which could provide innovative approaches for managing STAT3-dependent colonic disorders.
Insights
Signal transducer and activator of transcription 3 (STAT3) dysregulation is crucial in inflammatory bowel disease (IBD) and colorectal cancer (CRC). Modulating STAT3 signaling offers potential therapeutic strategies for these colonic disorders.
Area of Science:
- Molecular Biology
- Immunology
- Gastroenterology
Background:
- Signal transducer and activator of transcription 3 (STAT3) is a key regulator of inflammation and immune responses.
- Aberrant STAT3 activity (both hyperactivation and inactivation) is linked to various human diseases, including immunodeficiencies, autoimmune disorders, and cancers.
- STAT3 plays critical roles in vertebrate development and tissue function.
Purpose of the Study:
- To investigate the multifaceted roles of STAT3 in cellular processes relevant to colitis and colorectal cancer (CRC).
- To explore the implications of STAT3 dysregulation in inflammatory bowel disease (IBD) pathogenesis.
- To examine the role of STAT3 in the development and progression of CRC, particularly in inflammation-associated colitis.
Main Methods:
- Review of literature on STAT3's role in cellular processes.
- Analysis of STAT3's involvement in inflammatory pathways.
- Exploration of therapeutic strategies targeting STAT3 signaling.
Main Results:
- STAT3 is abnormally activated in colonic tissues in IBD, driven by pro-inflammatory cytokines, compromising the intestinal barrier.
- Persistent STAT3 activation is implicated in the pathogenesis of CRC, with elevated expression frequently observed.
- STAT3 influences proliferation, migration, differentiation, motility, and inflammatory responses.
Conclusions:
- STAT3 dysregulation significantly contributes to the pathology of IBD and CRC.
- Targeting STAT3 signaling pathways presents a promising therapeutic avenue for managing STAT3-dependent colonic disorders.
- Understanding STAT3's complex roles is essential for developing effective treatments for colitis and associated cancers.
More Related Videos
11:19Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
01:20The JAK-STAT Signaling Pathway
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: